Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort studyReportar como inadecuado




Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Percutaneous coronary intervention, Coronary artery disease, Smoking cessation, Coronary artery bypass grafting

Additional contributors:

Subject-Keyword: Percutaneous coronary intervention Coronary artery disease Smoking cessation Coronary artery bypass grafting

Type of item: Research Material

Language: English

Place:

Time:

Description: Background: Smoking is an undertreated risk factor for coronary artery disease CAD and is associated with adverse outcomes after myocardial infarction. Aims of our study were to determine if management of CAD by medical therapy MT alone or with coronary artery bypass grafting CABG or percutaneous coronary intervention PCI influence smoking status at one year following angiography and if a change in smoking status at one year influences long term survival. Methods: Prospective cohort study using the APPROACH registry. Two cohorts were examined: 1 11,334 patients who returned a one year follow-up questionnaire; 2 4,246 patients propensity-matched based on their post-angiography treatment - MT or revascularization RV. Multivariate modeling and survival analysis were used. Results: In the propensity-matched cohort, quit rates at one year were greater among CABG patients 68% than PCI 37% or MT patients 47%. Smokers in the RV group, who self-reported quitting at one year, had a significantly reduced mortality compared to those who continued to smoke. Conclusions: CABG patients were more likely to quit smoking than those treated with MT alone or PCI. Quitting smoking was associated with improved long-term survival; smoking remains a key risk factor for mortality in patients with CAD. These data underscore the importance of nicotine addiction management in patients with CAD and the need to emphasize cessation particularly in those patients undergoing MT or PCI.

Date created: 2014-10-20

DOI: doi:10.7939-R3H41JN9R

License information: Creative Commons Attribution-Non-Commercial-No Derivatives 3.0 Unported

Rights:





Autor: Hammal, Fadi Ezekowitz, Justin A. Norris, Colleen M. Wild, Cameron T. Finegan, Barry A

Fuente: https://era.library.ualberta.ca/


Introducción



Hammal et al.
BMC Cardiovascular Disorders 2014, 14:133 http:--www.biomedcentral.com-1471-2261-14-133 RESEARCH ARTICLE Open Access Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study Fadi Hammal1, Justin A Ezekowitz2,6, Colleen M Norris2,3,4,5, T Cameron Wild4, Barry A Finegan1*, for the APPROACH Investigators Abstract Background: Smoking is an undertreated risk factor for coronary artery disease (CAD) and is associated with adverse outcomes after myocardial infarction.
Aims of our study were to determine if management of CAD by medical therapy (MT) alone or with coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) influence smoking status at one year following angiography and if a change in smoking status at one year influences long term survival. Methods: Prospective cohort study using the APPROACH registry.
Two cohorts were examined: (1) 11,334 patients who returned a one year follow-up questionnaire; (2) 4,246 patients propensity-matched based on their post-angiography treatment - MT or revascularization (RV).
Multivariate modeling and survival analysis were used. Results: In the propensity-matched cohort, quit rates at one year were greater among CABG patients (68%) than PCI (37%) or MT patients (47%).
Smokers in the RV group, who self-reported quitting at one year, had a significantly reduced mortality compared to those who continued to smoke. Conclusions: CABG patients were more likely to quit smoking than those treated with MT alone or PCI.
Quitting smoking was associated with improved long-term survival; smoking remains a key risk factor for mortality in patients with CAD.
These data underscore the importance of nicotine addiction management in patients with CAD and the need to emphasize cessation particularly in those patients undergoing MT or PCI. Keywords: Smoking cessation, Coronary artery disease, Corona...





Documentos relacionados